A detailed history of Franklin Resources Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Franklin Resources Inc holds 16,660 shares of HBIO stock, worth $34,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,660
Previous 16,660 -0.0%
Holding current value
$34,652
Previous $44,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.64 - $3.54 $264 - $354
100 Added 0.6%
16,660 $44,000
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $886 - $1,481
320 Added 1.97%
16,560 $47,000
Q4 2023

Feb 09, 2024

BUY
$4.0 - $5.49 $2,368 - $3,250
592 Added 3.78%
16,240 $86,000
Q3 2023

Nov 13, 2023

BUY
$4.0 - $5.82 $62,592 - $91,071
15,648 New
15,648 $67,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $86.6M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.